ArticleAIDS and behavior2026
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South Africa.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Consistent adherence is essential for the effectiveness of daily oral pre-exposure prophylaxis (PrEP) in preventing HIV. Motivational interviewing (MI) and peer adherence support (PAS) are adherence support strategies, providing individualized support and may enhance both adherence to oral PrEP and continued use over time. This study aimed to evaluate the impact of implementation-adapted MI and PAS approaches on oral PrEP adherence and identify predictors of referral for adherence support. This MI/PAS intervention was embedded in the CAPRISA 084 PrEP demonstration study (2016-2018) and operated as a sequential, stepped adherence support approach rather than participant-selected alternatives: poor adherence triggered referral for MI, while participants with sustained/persistent adherence challenges (< 90% adherence on pill count or low drug levels) were escalated to PAS, a multi-component programme including SMS reminders, telephone support, and peer-support meetings. MI was delivered pragmatically and tailored to real-world clinical contexts rather than as a standardized intervention with no formal fidelity monitoring conducted. Tenofovir diphosphate levels from dried blood spots were measured in a subset of participants. We used Cox proportional hazards models to identify baseline predictors of MI/PAS referral; a paired t-test to assess changes in drug levels following referral, and a multivariable mixed-effects logistic model to evaluate associations between MI/PAS referral and subsequent visit attendance. Of 895 participants, 764 initiated PrEP, of whom 573 (75.0%) were referred for MI/PAS at a median of 88 (IQR:35-272) days after PrEP initiation. Multivariable analysis showed a higher likelihood of MI/PAS referral among urban residents (aHR 1.80, 95% CI 1.50-2.16), while being in a relationship > 5 years was protective (aHR 0.71, 95% CI 0.55-0.92). Participants referred for MI/PAS had nearly twice the odds of missing their subsequent visit compared with those not referred (OR 1.96; 95% CI 1.56-2.47). In a subset of 45 (5.9%) participants with drug-level data, tenofovir diphosphate concentrations increased significantly after MI/PAS (mean difference 154.7 fmol/punch; 95% CI 69.4-240; t(44) = 3.66; p < 0.001). MI/ PAS were implemented as targeted adherence support strategies within a PrEP implementation programme. Referral was influenced by relationship stability and site of care, and although recipients had poorer visit attendance, drug-level data showed meaningful improvements in adherence, supporting integration of MI/PAS-based support into PrEP delivery. Embedding MI/PAS alongside strengthened retention strategies, such as appointment reminders, community-based refills, and active follow-up of missed visits, may improve adherence, particularly for mobile urban populations.
Indexed as
Identifiers
42432403What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.